» Articles » PMID: 36246903

PTH, FGF-23, Klotho and Vitamin D As Regulators of Calcium and Phosphorus: Genetics, Epigenetics and Beyond

Overview
Specialty Endocrinology
Date 2022 Oct 17
PMID 36246903
Authors
Affiliations
Soon will be listed here.
Abstract

The actions of several bone-mineral ion regulators, namely PTH, FGF23, Klotho and 1,25(OH)2 vitamin D (1,25(OH)D), control calcium and phosphate metabolism, and each of these molecules has additional biological effects related to cell signaling, metabolism and ultimately survival. Therefore, these factors are tightly regulated at various levels - genetic, epigenetic, protein secretion and cleavage. We review the main determinants of mineral homeostasis including well-established genetic and post-translational regulators and bring attention to the epigenetic mechanisms that affect the function of PTH, FGF23/Klotho and 1,25(OH)D. Clinically relevant epigenetic mechanisms include methylation of cytosine at CpG-rich islands, histone deacetylation and micro-RNA interference. For example, sporadic pseudohypoparathyroidism type 1B (PHP1B), a disease characterized by resistance to PTH actions due to blunted intracellular cAMP signaling at the PTH/PTHrP receptor, is associated with abnormal methylation at the locus, thereby leading to reduced expression of the stimulatory G protein α-subunit (Gsα). Post-translational regulation is critical for the function of FGF-23 and such modifications include glycosylation and phosphorylation, which regulate the cleavage of FGF-23 and hence the proportion of available FGF-23 that is biologically active. While there is extensive data on how 1,25(OH)D and the vitamin D receptor (VDR) regulate other genes, much more needs to be learned about their regulation. Reduced VDR expression or VDR mutations are the cause of rickets and are thought to contribute to different disorders. Epigenetic changes, such as increased methylation of the VDR resulting in decreased expression are associated with several cancers and infections. Genetic and epigenetic determinants play crucial roles in the function of mineral factors and their disorders lead to different diseases related to bone and beyond.

Citing Articles

A novel LC-MS/MS analysis of vitamin D metabolites in mice serum and hair: impact of diet and light exposure.

Hakeem M, Al-Menhali A, Elangovan S, Shah I Front Endocrinol (Lausanne). 2025; 16:1494393.

PMID: 39980854 PMC: 11841401. DOI: 10.3389/fendo.2025.1494393.


Baseline fibroblast growth factor 23 predicts incident heart failure and cardiovascular mortality in patients with chronic kidney disease: A 3-year follow-up study.

Wang Y, Zhang D, Zhou R, Yang X, Wang X, Jiang Y Int J Cardiol Heart Vasc. 2025; 56():101587.

PMID: 39807363 PMC: 11728072. DOI: 10.1016/j.ijcha.2024.101587.


High Parathyroid Hormone Rather than Low Vitamin D Is Associated with Reduced Event-Free Survival in Childhood Cancer.

Grasemann C, Hoppner J, Hogler W, Tippelt S, Grasemann M, Grabow D Cancer Epidemiol Biomarkers Prev. 2024; 33(11):1414-1422.

PMID: 39141058 PMC: 11528194. DOI: 10.1158/1055-9965.EPI-24-0477.


Relationship between Femoral Proximal Bone Quality Assessment by MRI IDEAL-IQ Sequence and Body Mass Index in Elderly Men.

Goto K, Watanabe D, Kawae N, Nakamura T, Yanagida K, Yoshida T Tomography. 2024; 10(5):816-825.

PMID: 38787022 PMC: 11125441. DOI: 10.3390/tomography10050062.


Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease.

Korbut A, Romanov V, Klimontov V Biomedicines. 2024; 12(3).

PMID: 38540101 PMC: 10968590. DOI: 10.3390/biomedicines12030487.


References
1.
Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y . FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004; 19(3):429-35. DOI: 10.1359/JBMR.0301264. View

2.
Hsieh J, Jurutka P, Galligan M, Terpening C, Haussler C, Samuels D . Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. Proc Natl Acad Sci U S A. 1991; 88(20):9315-9. PMC: 52705. DOI: 10.1073/pnas.88.20.9315. View

3.
Martin T, Sims N, Seeman E . Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R. Endocr Rev. 2021; 42(4):383-406. DOI: 10.1210/endrev/bnab005. View

4.
Ide N, Olauson H, Sato T, Densmore M, Wang H, Hanai J . In vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling. Kidney Int. 2016; 90(2):348-362. DOI: 10.1016/j.kint.2016.04.009. View

5.
Khatami F, Gorji A, Khoshchehreh M, Mashhadi R, Pishkuhi M, Khajavi A . The correlation between promoter hypermethylation of VDR, CLDN, and CasR genes and recurrent stone formation. BMC Med Genomics. 2022; 15(1):109. PMC: 9092793. DOI: 10.1186/s12920-022-01265-1. View